IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 13,315

Sort by:

Chronic Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major chronic pain markets reached a value of US$ 21.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 28.9 Billion by 2034, exhibiting a growth rate (CAGR) of 2.9% du...

May 2024 140 pages

Chronic Pancreatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic pancreatitis markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 138 pages

Chronic Refractory Cough Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic refractory cough markets reached a value of US$ 9.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.1 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 132 pages

Chronic Sialorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic sialorrhea markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1...

May 2024 137 pages

Chronic Urticaria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major chronic urticaria markets reached a value of US$ 14.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 32.4 Million by 2034, exhibiting a growth rate (CAGR) of 7....

May 2024 137 pages

Chronic Venous Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic venous insufficiency markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The chronic venous insufficiency market has been comprehensively analyzed in IMARC's new repo...

May 2024 131 pages

Chronic Wounds Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic wounds markets reached a value of US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.6 Billion by 2034, exhibiting a growth rate (CAGR) of 2.96% d...

May 2024 131 pages

Churg-Strauss Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Churg-Strauss syndrome markets are expected to exhibit a CAGR of 4.51% during 2024-2034. The Churg-Strauss syndrome market has been comprehensively analyzed in IMARC's new report titled 'C...

May 2024 136 pages

Clostridium Difficile Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Clostridium difficile infection markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.9 Billion by 2034, exhibiting a growth rate...

May 2024 136 pages

Cluster Headache Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cluster headache markets reached a value of US$ 812.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,124.6 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 131 pages

CNS Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major CNS lymphoma markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The CNS lymphoma market has been comprehensively analyzed in IMARC's new report titled 'CNS Lymphoma Market:...

May 2024 138 pages

Coagulation Protein Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major coagulation protein disorders markets are expected to exhibit a CAGR of 7.6% during 2024-2034. The coagulation protein disorders market has been comprehensively analyzed in IMARC's new rep...

May 2024 137 pages

Coccidioidomycosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major coccidioidomycosis markets reached a value of US$ 132.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 209.5 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 135 pages

Cold Agglutinin Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cold agglutinin disease markets are expected to exhibit a CAGR of 16.2% during 2024-2034. The cold agglutinin disease market has been comprehensively analyzed in IMARC's new report titled...

May 2024 136 pages

Colorectal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major colorectal cancer markets reached a value of US$ 13.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 17.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2....

May 2024 140 pages

Common Cold Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major common cold markets are expected to exhibit a CAGR of 4.37% during 2024-2034. The common cold market has been comprehensively analyzed in IMARC's new report titled 'Common Cold Market: Epi...

May 2024 138 pages

Common Warts Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major common warts markets reached a value of US$ 761.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,056.6 Million by 2034, exhibiting a growth rate (CAGR) of 3.0...

May 2024 137 pages

Compartment Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major compartment syndrome markets reached a value of US$ 367.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 707.7 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Complement 3 Glomerulopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major complement 3 glomerulopathy markets reached a value of US$ 9.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.8 Billion by 2034, exhibiting a growth rate (CA...

May 2024 131 pages

Complicated Urinary Tract Infections (cUTIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major complicated urinary tract infections (cUTIs) markets are expected to exhibit a CAGR of 5.6% during 2024-2034. The complicated urinary tract infections (cUTIs) market has been comprehensive...

May 2024 136 pages

Concussions Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major concussions markets reached a value of US$ 792.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,069.3 Million by 2034, exhibiting a growth rate (CAGR) of 2.76...

May 2024 128 pages

Cone Rod Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cone rod dystrophy markets reached a value of US$ 114.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 179.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Congenital Adrenal Hyperplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major congenital adrenal hyperplasia markets reached a value of US$ 23.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 44.9 Million by 2034, exhibiting a growth rate...

May 2024 140 pages

Congenital Hyperinsulinism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major congenital hyperinsulinism markets reached a value of US$ 112.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 180.9 Million by 2034, exhibiting a growth rate (...

May 2024 134 pages

Congenital Ichthyosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The Congenital Ichthyosis market reached a value of US$ 5.0 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.0 Million by...

May 2024 128 pages

Contact Dermatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major contact dermatitis markets reached a value of US$ 10.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5...

May 2024 138 pages

Corneal Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major corneal dystrophy markets are expected to exhibit a CAGR of 6.1% during 2024-2034. The corneal dystrophy market has been comprehensively analyzed in IMARC's new report titled 'Corneal Dyst...

May 2024 132 pages

Coronary Heart Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major coronary heart disease markets are expected to exhibit a CAGR of 5.17% during 2024-2034. The coronary heart disease market has been comprehensively analyzed in IMARC's new report titled 'C...

May 2024 136 pages

Craniocerebral Trauma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major craniocerebral trauma markets are expected to exhibit a CAGR of 6.37% during 2024-2034. The craniocerebral trauma market has been comprehensively analyzed in IMARC's new report titled 'Cra...

May 2024 137 pages

Creutzfeldt-Jakob Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major creutzfeldt-jakob disease markets are expected to exhibit a CAGR of 17.2% during 2024-2034. The Creutzfeldt-Jakob disease market has been comprehensively analyzed in IMARC's new report tit...

May 2024 133 pages

Critical Limb Ischemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major critical limb ischemia markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 136 pages

Crohn's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Crohn's disease markets reached a value of US$ 8,319.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11,796.7 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 139 pages

Crow’s Feet Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major crow’s feet markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The crow’s feet market has been comprehensively analyzed in IMARC's new report titled 'Crow’s Feet Market: Epi...

May 2024 136 pages

Cryoglobulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cryoglobulinemia markets reached a value of US$ 339.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 548.3 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 129 pages

Cryopyrin-Associated Periodic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cryopyrin-associated periodic syndrome markets are expected to exhibit a CAGR of 4.23% during 2024-2034. The cryopyrin-associated periodic syndrome market has been comprehensively analyzed...

May 2024 134 pages

Cushing's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Cushing's syndrome markets reached a value of US$ 385.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 831.7 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Cutaneous Lupus Erythematosus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cutaneous lupus erythematosus markets reached a value of US$ 227.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 373.7 Million by 2034, exhibiting a growth rat...

May 2024 130 pages

Cutaneous Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cutaneous squamous cell carcinoma markets reached a value of US$ 7.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.0 Billion by 2034, exhibiting a growth ra...

May 2024 130 pages

Cutaneous T-Cell Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cutaneous T-cell lymphoma markets reached a value of US$ 428.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 628.7 Million by 2034, exhibiting a growth rate (C...

May 2024 139 pages

Cystic Fibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major cystic fibrosis markets reached a value of US$ 10,158.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 62,492.2 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 137 pages

Cystinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cystinuria markets reached a value of US$ 81.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 133.3 Million by 2034, exhibiting a growth rate (CAGR) of 4.61% du...

May 2024 129 pages

Cytomegalovirus Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cytomegalovirus infections markets are expected to exhibit a CAGR of 4.32% during 2024-2034. The cytomegalovirus infections market has been comprehensively analyzed in IMARC's new report t...

May 2024 128 pages

Deafness Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deafness markets are expected to exhibit a CAGR of 3.3% during 2024-2034. The deafness market has been comprehensively analyzed in IMARC's new report titled 'Deafness Market: Epidemiology,...

May 2024 140 pages

Deep Vein Thrombosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deep vein thrombosis markets reached a value of US$ 458.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 905.9 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Deglutition Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major deglutition disorders markets are expected to exhibit a CAGR of 4.1% during 2024-2034. The deglutition disorders market has been comprehensively analyzed in IMARC's new report titled 'Degl...

May 2024 138 pages

Delirium Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major delirium markets reached a value of US$ 187.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 283.0 Million by 2034, exhibiting a growth rate (CAGR) of 3.83% dur...

May 2024 140 pages

Dementia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dementia markets reached a value of US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.85% during...

May 2024 128 pages

Dengue Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dengue fever markets are expected to exhibit a CAGR of 10.21% during 2024-2034. The dengue fever market has been comprehensively analyzed in IMARC's new report titled 'Dengue Fever Market:...

May 2024 135 pages

Dermatomycosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dermatomycosis markets are expected to exhibit a CAGR of 3.47% during 2024-2034. The dermatomycosis market has been comprehensively analyzed in IMARC's new report titled 'Dermatomycosis Ma...

May 2024 128 pages

Dermatomyositis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dermatomyositis markets reached a value of US$ 192.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 278.0 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 128 pages

Filters

Clear all